Literature DB >> 11121193

Case with autistic syndrome and chromosome 22q13.3 deletion detected by FISH.

C Goizet1, E Excoffier, L Taine, E Taupiac, A A El Moneim, B Arveiler, M Bouvard, D Lacombe.   

Abstract

Autism is a rare neurodevelopmental disorder with a strong genetic component. Co-occurrence of autism and chromosomal abnormalities is useful to localize candidate regions that may include gene(s) implicated in autism determinism. Several candidate chromosomal regions are known, but association of chromosome 22 abnormalities with autism is unusual. We report a child with autistic syndrome and a de novo 22q13.3 cryptic deletion detected by FISH. Previously described cases with 22q13.3 deletions shared characteristic developmental and speech delay, but autism was not specifically reported. This case emphasizes a new candidate region that may bear a gene involved in autism etiopathogenesis. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:839-844, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11121193

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  16 in total

1.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

Authors:  M C Bonaglia; R Giorda; R Borgatti; G Felisari; C Gagliardi; A Selicorni; O Zuffardi
Journal:  Am J Hum Genet       Date:  2001-06-18       Impact factor: 11.025

Review 2.  Specific genetic disorders and autism: clinical contribution towards their identification.

Authors:  David Cohen; Nadège Pichard; Sylvie Tordjman; Clarisse Baumann; Lydie Burglen; Elsa Excoffier; Gabriela Lazar; Philippe Mazet; Clément Pinquier; Alain Verloes; Delphine Héron
Journal:  J Autism Dev Disord       Date:  2005-02

3.  Systematic screening for subtelomeric anomalies in a clinical sample of autism.

Authors:  Thomas H Wassink; Molly Losh; Joseph Piven; Val C Sheffield; Elizabeth Ashley; Erik R Westin; Shivanand R Patil
Journal:  J Autism Dev Disord       Date:  2007-04

4.  Sociability and motor functions in Shank1 mutant mice.

Authors:  Jill L Silverman; Sarah M Turner; Charlotte L Barkan; Seda S Tolu; Roheeni Saxena; Albert Y Hung; Morgan Sheng; Jacqueline N Crawley
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

5.  22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.

Authors:  S U Dhar; D del Gaudio; J R German; S U Peters; Z Ou; P I Bader; J S Berg; M Blazo; C W Brown; B H Graham; T A Grebe; S Lalani; M Irons; S Sparagana; M Williams; J A Phillips; A L Beaudet; P Stankiewicz; A Patel; S W Cheung; T Sahoo
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

Review 6.  Autism and cytogenetic abnormalities: solving autism one chromosome at a time.

Authors:  Christa Lese Martin; David H Ledbetter
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

7.  Partial tetrasomy of chromosome 3q and mosaicism in a child with autism.

Authors:  Guiomar Oliveira; Eunice Matoso; Astrid Vicente; Patricia Ribeiro; Carla Marques; Assunção Ataíde; Teresa Miguel; Jorge Saraiva; Isabel Carreira
Journal:  J Autism Dev Disord       Date:  2003-04

Review 8.  Glutamatergic candidate genes in autism spectrum disorder: an overview.

Authors:  Andreas G Chiocchetti; Hanna S Bour; Christine M Freitag
Journal:  J Neural Transm (Vienna)       Date:  2014-02-04       Impact factor: 3.575

9.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

10.  Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder.

Authors:  Ivon Cuscó; Andrés Medrano; Blanca Gener; Mireia Vilardell; Fátima Gallastegui; Olaya Villa; Eva González; Benjamín Rodríguez-Santiago; Elisabet Vilella; Miguel Del Campo; Luis A Pérez-Jurado
Journal:  Hum Mol Genet       Date:  2009-02-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.